Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Seynaeve

Showing results (71-80 of 104) with videos related to

Pageof 11
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 12, 2013
Substantial breast cancer risk reduction and potential survival benefit after bilateral mastectomy when compared with surveillance in healthy BRCA1 and BRCA2 mutation carriers: a prospective analysisB A M Heemskerk-Gerritsen, M B E Menke-Pluijmers, A Jager, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial riskC T Brekelmans, C Seynaeve, C C Bartels, et al.
Psycho-Oncology|February 26, 2011
Self-reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side-studyC M T Schilder, C Seynaeve, S C Linn, et al.
Critical Reviews in Oncology/Hematology|December 29, 2009
Cognitive functioning of postmenopausal breast cancer patients before adjuvant systemic therapy, and its association with medical and psychological factorsC M T Schilder, C Seynaeve, S C Linn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2009
Patterns of care in Dutch postmenopausal patients with hormone-sensitive early breast cancer participating in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trialJ G H van Nes, C Seynaeve, E Maartense, et al.
Lancet (London, England)|July 4, 1998
Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1L C Verhoog, C T Brekelmans, C Seynaeve, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Survival in hereditary breast cancer associated with germline mutations of BRCA2L C Verhoog, C T Brekelmans, C Seynaeve, et al.
Breast Cancer Research and Treatment|March 29, 2012
Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side studyJ G H van Nes, D B Y Fontein, E T M Hille, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2014
A randomized phase III study comparing pegylated liposomal doxorubicin with capecitabine as first-line chemotherapy in elderly patients with metastatic breast cancer: results of the OMEGA study of the Dutch Breast Cancer Research Group BOOGC H Smorenburg, S M de Groot, A E van Leeuwen-Stok, et al.
Plos One|May 23, 2015
Repeated nipple fluid aspiration: compliance and feasibility results from a prospective multicenter studyJ S de Groot, C B Moelans, S G Elias, et al.
Pageof 11

Showing results (71-80 of 104) with videos related to

Sort By:
Pageof 11
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 12, 2013
Substantial breast cancer risk reduction and potential survival benefit after bilateral mastectomy when compared with surveillance in healthy BRCA1 and BRCA2 mutation carriers: a prospective analysisB A M Heemskerk-Gerritsen, M B E Menke-Pluijmers, A Jager, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial riskC T Brekelmans, C Seynaeve, C C Bartels, et al.
Psycho-Oncology|February 26, 2011
Self-reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side-studyC M T Schilder, C Seynaeve, S C Linn, et al.
Critical Reviews in Oncology/Hematology|December 29, 2009
Cognitive functioning of postmenopausal breast cancer patients before adjuvant systemic therapy, and its association with medical and psychological factorsC M T Schilder, C Seynaeve, S C Linn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2009
Patterns of care in Dutch postmenopausal patients with hormone-sensitive early breast cancer participating in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trialJ G H van Nes, C Seynaeve, E Maartense, et al.
Lancet (London, England)|July 4, 1998
Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1L C Verhoog, C T Brekelmans, C Seynaeve, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Survival in hereditary breast cancer associated with germline mutations of BRCA2L C Verhoog, C T Brekelmans, C Seynaeve, et al.
Breast Cancer Research and Treatment|March 29, 2012
Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side studyJ G H van Nes, D B Y Fontein, E T M Hille, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2014
A randomized phase III study comparing pegylated liposomal doxorubicin with capecitabine as first-line chemotherapy in elderly patients with metastatic breast cancer: results of the OMEGA study of the Dutch Breast Cancer Research Group BOOGC H Smorenburg, S M de Groot, A E van Leeuwen-Stok, et al.
Plos One|May 23, 2015
Repeated nipple fluid aspiration: compliance and feasibility results from a prospective multicenter studyJ S de Groot, C B Moelans, S G Elias, et al.
Pageof 11